Stanozolol is indicated in disorders of protein synthesis, cachexia of various genesis; trauma, burns, pre- and postoperative and post-irradiation infectious diseases; renal and adrenal glands, toxic goiter, muscular dystrophy, osteoporosis, negative nitrogen balance with corticosteroids, hypoglycemic and aplastic anemia. Prophylactic for decreasing the frequency and severity of access to hereditary angioedema.
Adjuvant in the treatment of tuberculosis, osteomyelitis, asthma, hepatitis.
Stanozolol is not indicated in patients with hypersensitivity to the drug, prostate cancer, breast cancer in men, breast cancer in women with hypercalcemia, severe atherosclerosis, liver and kidney failure, acute and chronic prostatitis, pregnancy and lactation.
The optimal dose for adults is 10-20 mg / day. The preservation dose is 5-10 mg / day.
To minimize the frequency and severity of hereditary angioedema attacks, individual doses were adjusted according to the patient's response. Starting with a dose of 2 mg 3 times a day. When a positive effect is obtained, the dose is gradually reduced over a period of 1 to 3 months to 2 mg daily.
Stanozolol is an anabolic steroid. This drug stimulates anabolic processes and inhibits catabolic ones caused by glucocorticoids. Stanozole induces the increase of muscle mass, reduces fat deposits, improves trophic tissues, promotes the deposition of calcium in the bones, retains nitrogen, phosphorus, sulfur, potassium, sodium and water in the body. Hematopoietic activity is caused by increased levels of erythropoietin synthesis.
The antiallergic action is caused by the increase in the C1 complement fraction in the serum. Moderate androgenic activity may lead to the development of secondary male sexual characteristics.
If you experience the first signs of virilization (deepening of the voice, hirsutism, acne, clitoromegaly), stop taking this medicine to avoid unwanted side effects. Systematic monitoring of lipid levels and cholesterol is required. Pediatric use should be performed by an experienced specialist to avoid premature epiphyseal bone calcification.
Stanozol can cause various side effects in women and men. They have different symptoms in men and women, but may be the same in some cases.
Women - virilizing symptoms, inhibition of ovarian function, menstrual disorders, hypercalcemia.
Men: in symptoms of prepubertal virilization, idiopathic cutaneous hyperpigmentation, retention or stunting of growth (calcification of areas of epiphyseal growth of tubular bones); during postpubertal-bladder irritation, gynecomastia, priapism; the elderly - hypertrophy and / or prostate cancer.
Men and women - progression of atherosclerosis, peripheral edema, impaired liver function with jaundice, changes in blood count, long tubular bone pain, hypo-coagulation coagulation prone to bleeding.
In case of an overdose with Stanozol, seek emergency help.